학술논문

Updated results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination Lu-177 PSMA 617 and idronoxil in men with mCRPC post androgen signalling inhibition and taxane chemotherapy (LuPIN trial).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2020, 38 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755